data13F

MIRM – Mirum Pharmaceuticals Inc

Held by 1 of 60 tracked investors in their latest 13F filing

Investors holding1
Combined shares32,129
Combined reported value$2.7M

MIRM chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Polen Capital 0.03 Added 53.7%32,129$2.7MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Polen Capital Added 53.7%32,1290.01
Q2 2026Polen Capital Added 1.8%20,8990.00
Q1 2026Polen Capital Added 53.7%20,5310.00
Q1 2026Paul Tudor Jones narrow view Closed00.00
Q4 2025Paul Tudor Jones narrow view Reduced 81.2%5,2050.01
Q4 2025Polen Capital Added 0.2%13,3600.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Polen Capital Added 53.7%32,1290.01
Q2 2026Polen Capital Added 1.8%20,8990.00
Q1 2026Polen Capital Added 53.7%20,5310.00
Q4 2025Polen Capital Added 0.2%13,3600.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q1 2026Paul Tudor Jones narrow view Closed00.00
Q4 2025Paul Tudor Jones narrow view Reduced 81.2%5,2050.01

History

2 peakQ3 2026: 1 tracked investors
Q4 2020: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2023: 1 tracked investorsQ4 2024: 1 tracked investorsQ2 2025: 1 tracked investorsQ3 2025: 2 tracked investorsQ4 2025: 2 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20202026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Polen Capital32.1K20.9K20.5K13.4K13.3K15.5K––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).